PROK
Price
$2.30
Change
-$0.06 (-2.54%)
Updated
Sep 2 closing price
Capitalization
310.49M
76 days until earnings call
RYTM
Price
$104.21
Change
+$1.06 (+1.03%)
Updated
Sep 2 closing price
Capitalization
6.92B
69 days until earnings call
Interact to see
Advertisement

PROK vs RYTM

Header iconPROK vs RYTM Comparison
Open Charts PROK vs RYTMBanner chart's image
ProKidney
Price$2.30
Change-$0.06 (-2.54%)
Volume$1.25M
Capitalization310.49M
Rhythm Pharmaceuticals
Price$104.21
Change+$1.06 (+1.03%)
Volume$755.31K
Capitalization6.92B
PROK vs RYTM Comparison Chart in %
Loading...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PROK vs. RYTM commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PROK is a Buy and RYTM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (PROK: $2.30 vs. RYTM: $104.21)
Brand notoriety: PROK and RYTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PROK: 7% vs. RYTM: 99%
Market capitalization -- PROK: $310.49M vs. RYTM: $6.92B
PROK [@Biotechnology] is valued at $310.49M. RYTM’s [@Biotechnology] market capitalization is $6.92B. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PROK’s FA Score shows that 0 FA rating(s) are green whileRYTM’s FA Score has 1 green FA rating(s).

  • PROK’s FA Score: 0 green, 5 red.
  • RYTM’s FA Score: 1 green, 4 red.
According to our system of comparison, RYTM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PROK’s TA Score shows that 3 TA indicator(s) are bullish while RYTM’s TA Score has 3 bullish TA indicator(s).

  • PROK’s TA Score: 3 bullish, 5 bearish.
  • RYTM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RYTM is a better buy in the short-term than PROK.

Price Growth

PROK (@Biotechnology) experienced а -3.36% price change this week, while RYTM (@Biotechnology) price change was +2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.48%. For the same industry, the average monthly price growth was +24.35%, and the average quarterly price growth was +32.72%.

Reported Earning Dates

PROK is expected to report earnings on Nov 18, 2025.

RYTM is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.48% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($6.92B) has a higher market cap than PROK($310M). RYTM YTD gains are higher at: 84.262 vs. PROK (39.645). PROK (-157.52M) and RYTM (-159.11M) have comparable annual earnings (EBITDA) . PROK (295M) and RYTM (291M) have equal amount of cash in the bank . RYTM has less debt than PROK: RYTM (4.19M) vs PROK (4.42M). RYTM has higher revenues than PROK: RYTM (156M) vs PROK (527K).
PROKRYTMPROK / RYTM
Capitalization310M6.92B4%
EBITDA-157.52M-159.11M99%
Gain YTD39.64584.26247%
P/E RatioN/AN/A-
Revenue527K156M0%
Total Cash295M291M101%
Total Debt4.42M4.19M105%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
17
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PROKRYTM
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
72%
Bearish Trend 5 days ago
87%
Momentum
ODDS (%)
Bullish Trend 5 days ago
66%
Bullish Trend 5 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
69%
Bearish Trend 5 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
72%
Bullish Trend 5 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
74%
Bearish Trend 5 days ago
83%
Aroon
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGIWX12.90-0.02
-0.15%
Nuveen Global Infrastructure R6
TLISX13.57-0.02
-0.15%
Nuveen Quant Intl Small Cap Eq A
GAFFX85.46-0.80
-0.93%
American Funds Growth Fund of Amer F3
FKIDX16.79-0.16
-0.94%
Fidelity Diversified Intl K6
NESIX19.99-0.31
-1.53%
Needham Small Cap Growth Institutional

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with CYCC. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then CYCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-5.60%
CYCC - PROK
57%
Loosely correlated
+5.31%
MBIO - PROK
51%
Loosely correlated
-2.27%
RLYB - PROK
45%
Loosely correlated
-4.21%
RYTM - PROK
40%
Loosely correlated
-1.04%
NRIX - PROK
39%
Loosely correlated
-0.74%
More

RYTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with VRNA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then VRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RYTM
1D Price
Change %
RYTM100%
-1.04%
VRNA - RYTM
45%
Loosely correlated
+0.03%
CRNX - RYTM
44%
Loosely correlated
+1.11%
RVMD - RYTM
42%
Loosely correlated
-0.93%
NRIX - RYTM
41%
Loosely correlated
-0.74%
IDYA - RYTM
40%
Loosely correlated
-1.52%
More